Taxotere® (TXT) versus best supportive care (BSC) in chemonaive patients with unresectable non-small cell lung cancer (NSCLC): Final results of the phase iii study

1999 ◽  
Vol 35 ◽  
pp. S246 ◽  
Author(s):  
K. Roszkowski
Keyword(s):  
Lung Cancer ◽  
Supportive Care ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Best Supportive Care ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study

Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. CRA8000-CRA8000
Author(s):  
C. P. Belani ◽  
T. Brodowicz ◽  
T. Ciuleanu ◽  
J. H. Kim ◽  
M. Krzakowski ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Supportive Care ◽  
Small Cell Lung Cancer ◽  
Annual Meeting ◽  
Best Supportive Care ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Final Text

CRA8000 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document